4 ms·

Great, then get the FDA to approve more people to make lifesaving drugs? A system where you're counting on the generosity of companies to charge low prices seem

Great, then get the FDA to approve more people to make lifesaving drugs? A system where you're counting on the generosity of companies to charge low prices seems rather flawed. Only a couple thousand people use Daraprim in the US. He claims 2/3rd of sales are to the USG at 1c per pill. So if there's 700 full price patients at $100K a course, that's an extra $70M on 3 trillion? Companies were doing this before he did, and keep doing it now. So get the FDA to change or have a "dire needs" import rule or fix the system.

Clubber 9y ago
>A system where you're counting on the generosity of companies to charge low prices seems rather flawed. Oh, it is absolutely flawed and completely corrupt. It's so corrupt it's costing lives rather than just money. I'm not saying it's happening, but I wouldn't be surprised if the FDA's mandates and budget for approval aren't somehow related to keeping profits high.